Marentette M - Search Results

1

Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada.

Kohli M, Attard C, Lam A, Huse D, Cook J, Bourgault C, Alemao E, Yin D, Marentette M. Kohli M, et al. Among authors: marentette m. Pharmacoeconomics. 2006;24(8):815-30. doi: 10.2165/00019053-200624080-00007. Pharmacoeconomics. 2006. PMID: 16898850

2

Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective.

Marshall JK, Pellissier JM, Attard CL, Kong SX, Marentette MA. Marshall JK, et al. Among authors: marentette ma. Pharmacoeconomics. 2001;19(10):1039-49. doi: 10.2165/00019053-200119100-00005. Pharmacoeconomics. 2001. PMID: 11735672

3

Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).

Bourgault C, Davignon J, Fodor G, Gagné C, Gaudet D, Genest J, Lavoie MA, Leiter L, McPherson R, Sénécal M, Marentette M, Sebaldt RJ. Bourgault C, et al. Among authors: marentette m. Can J Cardiol. 2005 Nov;21(13):1187-93. Can J Cardiol. 2005. PMID: 16308595

4

Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.

Bourgault C, Sénécal M, Brisson M, Marentette MA, Grégoire JP. Bourgault C, et al. Among authors: marentette ma. J Hum Hypertens. 2005 Aug;19(8):607-13. doi: 10.1038/sj.jhh.1001873. J Hum Hypertens. 2005. PMID: 15920457

5

Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population.

Rahme E, Marentette MA, Kong SX, Lelorier J. Rahme E, et al. Among authors: marentette ma. Arthritis Rheum. 2002 Dec 15;47(6):595-602. doi: 10.1002/art.10796. Arthritis Rheum. 2002. PMID: 12522832 Free article.

6

Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.

Sebaldt RJ, Petrie A, Goldsmith CH, Marentette MA. Sebaldt RJ, et al. Among authors: marentette ma. Am J Manag Care. 2004 Nov;10(11 Pt 1):742-50. Am J Manag Care. 2004. PMID: 15623264 Free article.

7

Antihypertensive persistence and drug class.

Marentette MA, Gerth WC, Billings DK, Zarnke KB. Marentette MA, et al. Can J Cardiol. 2002 Jun;18(6):649-56. Can J Cardiol. 2002. PMID: 12107422

8

Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.

Burgess ED, Carides GW, Gerth WC, Marentette MA, Chabot I; Canadian Hypertension Society. Burgess ED, et al. Among authors: marentette ma. Can J Cardiol. 2004 May 1;20(6):613-8. Can J Cardiol. 2004. PMID: 15152291 Clinical Trial.

9

Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study--observational.

Sénécal M, Fodor G, Gagné C, Genest J, Lavoie MA, McPherson R, Marentette M, Sebaldt RJ. Sénécal M, et al. Among authors: marentette m. Curr Med Res Opin. 2009 Jan;25(1):47-55. doi: 10.1185/03007990802575734. Curr Med Res Opin. 2009. PMID: 19210138

10

Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.

Lambert J, Carides GW, Meloche JP, Gerth WC, Marentette MA. Lambert J, et al. Among authors: marentette ma. Can J Clin Pharmacol. 2002 Fall;9(3):158-64. Can J Clin Pharmacol. 2002. PMID: 12422253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters